Brinavess (vernakalant): Reviews and patient testimonials
Medication indications
Brinavess 20 mg/ml concentrate for solution for infusion
Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults-For non-surgery patients: atrial fibrillation ≤ 7 days duration-For post-cardiac surgery patients: atrial fibrillation ≤ 3 days durationRoute of administration: Injectable
Molecule: vernakalant
Patients' opinions on Brinavess
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.